CTR-FAPI PET Enables Precision Management of Medullary Thyroid CarcinomaZiren Kong, Shaoyan Liu, Zhibo Liu et al.|Cancer Discovery|2024Cited by 23
Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancerXiaowei Chen, Shugeng Gao, Guangyu Bai et al.|Translational Oncology|2023Cited by 14
Covalent FAPI PET enables accurate management of medullary thyroid carcinoma: A prospective single-arm comparative clinical trial.Ziren Kong, Shaoyan Liu, Li Zhu et al.|Journal of Clinical Oncology|2024Cited by 1
Supplementary Figure 3 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid CarcinomaZiren Kong, Shaoyan Liu, Zhu Li et al.|Unknown|2025Cited by 0
Supplementary Table 14 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid CarcinomaZiren Kong, Shaoyan Liu, Xi‐Yang Cui et al.|Unknown|2025Cited by 0